Lipidor AB (publ) L7R.F Stock
Lipidor AB (publ) Price Chart
Lipidor AB (publ) L7R.F Financial and Trading Overview
| Lipidor AB (publ) stock price | 0.01 EUR |
| Previous Close | 0.12 EUR |
| Open | 0.11 EUR |
| Bid | 0.12 EUR x N/A |
| Ask | 0.14 EUR x N/A |
| Day's Range | 0.11 - 0.11 EUR |
| 52 Week Range | 0.02 - 0.86 EUR |
| Volume | 3K EUR |
| Avg. Volume | 53 EUR |
| Market Cap | 3.85M EUR |
| Beta (5Y Monthly) | -0.014238 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.05 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
L7R.F Valuation Measures
| Enterprise Value | 2.74M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Lipidor AB (publ) Stock Price History
| Beta (5Y Monthly) | -0.014238 |
| 52-Week Change | -82.79% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.86 EUR |
| 52 Week Low | 0.02 EUR |
| 50-Day Moving Average | 0.05 EUR |
| 200-Day Moving Average | 0.22 EUR |
L7R.F Share Statistics
| Avg. Volume (3 month) | 53 EUR |
| Avg. Daily Volume (10-Days) | 300 EUR |
| Shares Outstanding | 28.98M |
| Float | 18.46M |
| Short Ratio | N/A |
| % Held by Insiders | 42.52% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -76.067% |
| Return on Equity (ttm) | -170.72% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | -66.70% |
| Gross Profit (ttm) | -29730000 EUR |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.06 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.973 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Lipidor AB (publ)
| Country | Germany |
| State | N/A |
| City | Danderyd |
| Address | Svärdvägen 13 |
| ZIP | 182 33 |
| Phone | 46 7 25 07 03 69 |
| Website | https://lipidor.se |
| Industry | Drug Manufacturers-General |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Lipidor AB (publ), a pharmaceutical development company, engages in the development of drugs for the treatment of psoriasis, acne vulgaris, bacterial skin infections, and atopic dermatitis. The company develops AKP-01, which is in Phase III for the treatment of psoriasis; and preclinical stage products, such as AKP-02 for psoriasis, AKP-03 for bacterial skin diseases, and AKP-07 for atopic dermatitis. It offers active pharmaceutical ingredients used in products for various therapeutic applications, such as anti-psoriasic, antimicrobial, anti-inflammatory, antifungal, local anesthetics, non-steroidal anti-inflammatory, anti-acne, wound healing, anti-eczema, and anti-migraine. The company also develops a range of spray products for animal skin care in dogs, cats, and horses; and consumer health care products for applications, including antibacterial, antiseptic, moisturizing emollient, disinfectant, and acne and wart treatment. It has a collaboration agreement with Cannassure Therapeutics Ltd. for the development of topical medicinal cannabis products for the treatment of skin inflammations and psoriatic lesions. The company was incorporated in 2009 and is based in Danderyd, Sweden.
Q&A For Lipidor AB (publ) Stock
What is a current L7R.F stock price?
Lipidor AB (publ) L7R.F stock price today per share is 0.01 EUR.
How to purchase Lipidor AB (publ) stock?
You can buy L7R.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Lipidor AB (publ)?
The stock symbol or ticker of Lipidor AB (publ) is L7R.F.
Which industry does the Lipidor AB (publ) company belong to?
The Lipidor AB (publ) industry is Drug Manufacturers-General.
How many shares does Lipidor AB (publ) have in circulation?
The max supply of Lipidor AB (publ) shares is 47.1M.
What is Lipidor AB (publ) Price to Earnings Ratio (PE Ratio)?
Lipidor AB (publ) PE Ratio is now.
What was Lipidor AB (publ) earnings per share over the trailing 12 months (TTM)?
Lipidor AB (publ) EPS is -0.05 EUR over the trailing 12 months.
Which sector does the Lipidor AB (publ) company belong to?
The Lipidor AB (publ) sector is Healthcare.